Transparency Launches as Linux of Drug Development
Then Sablinski read an article about the open-source operating system Linux and he had an epiphany. “If said, ‘If computer coders can do open source, so can drug developers,” he recalls. “You have to...
View ArticleThe Case for Transparency – AVANDIA?
In December, I argued for more transparency in relation to clinical trials, and hoped that the Commission would take up this issue in the forthcoming revision of the Clinical Trials Directive. I...
View ArticleSpecial Report: When the Drugs Don't Work
Welcome to a world where the drugs don't work...for decades scientists have managed to develop new medicines to stay at least one step ahead of an ever-mutating enemy.Now, though, we may be running out...
View ArticleOpen Source Drug Discovery
Drug discovery is challenging, lengthy, and extraordinarily expensive. All companies focus on making money and drug companies are no different. They spend their research and development budgets...
View ArticleNow We're Talking!
It's articles like the one recently published in the New York Times that so powerfully demonstrate the value of open source methods, in this case the value of data sharing and collaboration. The...
View ArticleClik here to view.
How Can Open Source Projects Support Themselves in Health Care?
High prices and poor usability hasn't driven the health care industry away from megalithic, proprietary applications. What may win the industry over to open source (in addition to the hope of fixing...
View ArticleCrowd-Sourcing Drug Discovery
Each year, India tallies 1.7 million cases of tuberculosis (TB) and some 400,000 people succumb to the disease, making it the leading cause of death for those in the prime of life, from 15 to 45 years...
View ArticleCould Open Source Principles Revolutionize Drug Development?
...a startup company is applying open source principles to, of all things, drug development. Transparency Life Sciences may have a shot at invoving patients in drug development in unprecedented ways,...
View ArticleACTA Goes Too Far, Says MEP
The French MEP who resigned his position in charge of negotiating the international Anti-Counterfeiting Trade Agreement (ACTA) has said it "goes too far" by potentially cutting access to lifesaving...
View ArticleTransparency Launches as Linux of Drug Development
Then Sablinski read an article about the open-source operating system Linux and he had an epiphany. “If said, ‘If computer coders can do open source, so can drug developers,” he recalls. “You have to...
View ArticleThe Case for Transparency – AVANDIA?
In December, I argued for more transparency in relation to clinical trials, and hoped that the Commission would take up this issue in the forthcoming revision of the Clinical Trials Directive. I...
View ArticleSpecial Report: When the Drugs Don't Work
Welcome to a world where the drugs don't work...for decades scientists have managed to develop new medicines to stay at least one step ahead of an ever-mutating enemy.Now, though, we may be running out...
View ArticleOpen Source Drug Discovery
Drug discovery is challenging, lengthy, and extraordinarily expensive. All companies focus on making money and drug companies are no different. They spend their research and development budgets...
View ArticleNow We're Talking!
It's articles like the one recently published in the New York Times that so powerfully demonstrate the value of open source methods, in this case the value of data sharing and collaboration. The...
View ArticleClik here to view.
How Can Open Source Projects Support Themselves in Health Care?
High prices and poor usability hasn't driven the health care industry away from megalithic, proprietary applications. What may win the industry over to open source (in addition to the hope of fixing...
View ArticleCrowd-Sourcing Drug Discovery
Each year, India tallies 1.7 million cases of tuberculosis (TB) and some 400,000 people succumb to the disease, making it the leading cause of death for those in the prime of life, from 15 to 45 years...
View ArticleCould Open Source Principles Revolutionize Drug Development?
...a startup company is applying open source principles to, of all things, drug development. Transparency Life Sciences may have a shot at invoving patients in drug development in unprecedented ways,...
View ArticleACTA Goes Too Far, Says MEP
The French MEP who resigned his position in charge of negotiating the international Anti-Counterfeiting Trade Agreement (ACTA) has said it "goes too far" by potentially cutting access to lifesaving...
View Article
